Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Removing T-cell epitopes with computational protein design.

Chris King1, Esteban N Garza2, Ronit Mazor3

  • 1Institute for Protein Design, Department of Biochemistry and chrisk1@uw.edu.

Proceedings of the National Academy of Sciences of the United States of America
|May 21, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Considerations for Regional Anaesthesia in the Prehospital Environment.

Air medical journal·2025
Same author

Anesthetic Management and Considerations During Surgical Dissection of a Schwannoma Causing Severe Cervical Spinal Canal Stenosis and Vertebral Artery Compression.

Cureus·2024
Same author

Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.

Trials·2024
Same author

EEG Complexity Analysis of Brain States, Tasks and ASD Risk.

Advances in neurobiology·2024
Same author

Patients treated for acute headache with intranasal droperidol spend less time in the emergency department: A retrospective observational study.

Emergency medicine Australasia : EMA·2022
Same author

THE PREVALENCE OF INSOMNIA AND SLEEP APNEA IN DISCHARGE ABSTRACT DATA: A CALL TO IMPROVE DATA QUALITY.

Perspectives in health information management·2021

Computational protein design can reduce immunogenicity by removing T-cell epitopes. This method enhances protein therapeutics safety and efficacy by minimizing immune responses without affecting protein structure or function.

Area of Science:

  • Biochemistry
  • Immunology
  • Computational Biology

Background:

  • Immune responses against protein therapeutics can lead to reduced efficacy and adverse events.
  • T-cell epitopes are key targets for immune recognition and subsequent therapeutic failure.
  • Minimizing immunogenicity is crucial for developing safer and more effective protein-based drugs.

Purpose of the Study:

  • To present a general computational protein design method for reducing immunogenicity.
  • To eliminate known and predicted T-cell epitopes while maximizing human peptide sequence content.
  • To ensure that protein structure and function are preserved during the design process.

Main Methods:

  • Utilized a computational approach for protein sequence optimization.
Keywords:
Rosettabiotherapeuticsdeimmunizationimmunotoxinmachine learning

Related Experiment Videos

  • Identified and removed T-cell epitopes using predictive algorithms.
  • Incorporated human peptide sequences to enhance biocompatibility.
  • Validated the method against existing experimental data on immunogenicity reduction.

    • Main Results:

    • The computational method successfully reduced T-cell epitopes in target proteins.
    • Protein function and structure were maintained after computational design.
    • The approach demonstrated recapitulation of previous experimental immunogenicity reduction findings.
    • Applied to Green Fluorescent Protein (GFP) and Pseudomonas exotoxin A, demonstrating epitope disruption without functional loss.

    Conclusions:

    • A general computational protein design strategy effectively reduces immunogenicity.
    • This method offers a promising approach for engineering safer protein therapeutics.
    • Preservation of protein structure and function is achievable alongside immunogenicity reduction.